A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma
Clinical trial NCT00585000 · TERMINATED
Trial details
- NCT number
- NCT00585000
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-01-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.